AMGEN BIOFARMACEUTICA, LDA secures contract for Evolocumab 140 Mg/1 Ml Sol Inj Pen 1 Ml Sc

Portugal, Jan. 5 -- Portugal based AMGEN BIOFARMACEUTICA, LDA has secured contract from Unidade Local De Saude De Almada-Seixal, E.P.E. for Evolocumab 140 Mg/1 Ml Sol Inj Pen 1 Ml Sc. The value of the contract is worth 3536800 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....